Allen, L.V., Popovich, N.G., Ansel, H.C.Ansel’s pharmaceutical dosage forms and drug delivery systems, 8th edn. Philadelphia: Lippincott Williams & Wilkins, 2004.

Aulton, M.E.Aulton’s pharmaceutics: the design and manufacture of medicines, 3rd edn. Edinburgh: Churchill Livingstone, 2007.

Aulton, M.E., Taylor, K.Aulton’s pharmaceutics: the design and manufacture of medicines, 4th edn. Edinburgh: Churchill Livingstone, 2013.

British National Formulary, current edition. British Medical Association and Royal Pharmaceutical Society, London.

British National Formulary for children, current edition. London: British Medical Association, Royal Pharmaceutical Society and Royal College of Paediatrics and Child Health.

British Pharmaceutical Codex 1973 Pharmaceutical Press, London.

British Pharmacopoeia, current edition. Stationery Office, London.

Committee of Inquiry Into Pharmacy: a report to the Nuffield Foundation 1986 Nuffield Foundation, London.

Department of Health. Online. Available:<www.dh.gov.uk>.

Department of Health, DHAn organisation with a memory: a report from an expert working group on learning from adverse events in the NHS. London: Department of Health, 2000.

European Pharmacopoeia, current edition and supplements. Maisonneuve, Saint Ruffine.

Farwell J. 1995 Aseptic dispensing for NHS patients (the Farwell Report). Stationery Office, London.

General Pharmaceutical Council. Online. Available:<www.pharmacyregulation.org>.

General Pharmaceutical Council. GPhC Standards of conduct, ethics and performance. Online. Available:<www.pharmacyregulation.org>.

Handbook of pharmaceutical excipients, current edition. Pharmaceutical Press, London.

Marriott, J.F., Wilson, K.A., Langley, C.A., et alPharmaceutical compounding and dispensing. London: Pharmaceutical Press, 2006.

Martindale: The Complete Drug Reference. Pharmaceutical Press, London.

Martindale: The Extra Pharmacopoeia. Pharmaceutical Press, London.

Medicines compendium, current edition. Datapharm Publications, London.

Medicines Control Agency, 2002. Rules and guidance for pharmaceutical manufacture. Stationery Office, London.

Medicines and Healthcare Regulatory Authority, MHRA. Online. Available:<www.MHRA.gov.uk>.

National Institute for Health and Care Excellence, NICE. Online. Available:<www.nice.gov.uk>.

National Prescribing Centre. Online. Available:<www.npc.co.uk>.

Pharmaceutical codex, 11th edn. 1979 Pharmaceutical Press, London.

Pharmaceutical codex, 12th edn. 1994 Pharmaceutical Press, London.

Pharmaceutical Services Negotiating Committee. Online. Available:<www.psnc.org.uk>.

Stephens, M.Hospital pharmacy. London: Pharmaceutical Press, 2002.

Stone, P., Curtis, S.J.Pharmacy practice, 3rd edn. London: Pharmaceutical Press, 2002.

United States pharmacopoeia, current edition. Mack, Easton.

Wade E., ed. Pharmaceutical handbook, 19th edn. London: Pharmaceutical Press, 1980.

Walker, R., Whittlesea, C.Clinical pharmacy and therapeutics, 5th edn. Edinburgh: Churchill Livingstone, 2012.

Waterfield, J.Community pharmacy handbook. London: Pharmaceutical Press, 2008.

Section One: An introduction to pharmacy and its place in society

Chapter 1: The role of pharmacy in health care

Bond, C.Evidence-based pharmacy. London: Pharmaceutical Press, 2000.

Clinical Resources Audit Group, l996. Clinical pharmacy in the hospital pharmaceutical service: a framework for practice. Stationery Office, Edinburgh.

Department of Health, DoH, 1996. Choice and opportunity. Primary care: the future. Stationery Office, London.

Department of Health, DH, 2001. Response to the report of the public inquiry into children’s heart surgery at the Bristol Royal Infirmary, 1984–1995. Stationery Office, London.

Department of Health, DH, 2002. Pharmacy in the future: implementing the NHS plan – a programme for pharmacy in the National Health Service. Stationery Office, London.

Royal Pharmaceutical Society of Great Britain, l996. Pharmacy in a new age: the new horizon. Royal Pharmaceutical Society of Great Britain, London.

Scottish Executive, 2002. The right medicine: a strategy for pharmaceutical care in Scotland. Stationery Office, London.

Weller P.J. (ed.) Pharmacists’ directory and yearbook, current edition. Royal Pharmaceutical Society of Great Britain, London.

Chapters 2 and 3: Socio-behavioural aspects of health, illness and treatment with medicines

Abraham, C., Conner, M., Jones, F., et alHealth psychology: topics in applied psychology. London: Hodder Education, 2008.

Allardt E. 1973. About dimensions of welfare – Research Group for Comparative Sociology. Research Report No. 1. University of Helsinki, Helsinki.

Bernstein, L., Bernstein, R.S., Emotions in illness and treatmentInterviewing: a guide for health professionals, 4th edn. New York: Appleton-Century Crofts, 1985.

Bissell, P., Traulsen, J.M.Sociology and pharmacy practice. London: Pharmaceutical Press, 2005.

Bond C., ed. Concordance. London: Pharmaceutical Press, 2004.

Britten, N., Stevenson, F.A., Barry, C.A., et al. Misunderstandings in prescribing decisions in general practice: qualitative study. British Medical Journal. 2000; 320:484–488.

Charles, C., Gafni, A., Whelan, T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Social Science and Medicine. 1997; 44:681–692.

Charles, C., Gafni, A., Whelan, T. Decision making in the physician-patient encounter: revisiting the shared decision making model. Social Science and Medicine. 1999; 49:651–661.

Cleary, P.D., McNeil, B.J. Patient satisfaction as an indicator of quality care. Inquiry. 1988; 25:25–26.

Donabedian A. 2005 [1966]. Evaluating the quality of medical care. Reprinted in The Milbank Quarterly 83(4): 691–729.

FIP (International Pharmaceutical Federation). Standards for quality of pharmacy services. Online. Available:<www.fip.org>.

Florence, A.T., Taylor, K.M.G., Harding, G.Pharmacy practice. London: Taylor and Francis, 2001.

Friedman, M., Rosenman, R.H.Type A behaviour and your heart. New York: Random House, 1974.

Gard, P.A behavioural approach to pharmacy practice. Oxford: Wiley Blackwell, 2000.

Hope, T.Evidence based patient choice. London: King’s Fund, 1996.

Kasl, S.V., Cobb, S. Health behaviour, illness behaviour and sick role behaviour. Archives of Environmental Research. 1966; 12:246–247.

Kosma, C.M., Reeder, C.E., Schultz, R.E. Economic, clinical and humanistic outcomes: a planning model for pharmacoeconomic research. Clinical Therapeutics. 1993; 15(6):1121–1132.

Lewis, R., Maude, A.Professional people. London: Phoenix House, 1952.

Lilja J., Larsson S., Hamilton D., 1996. Drug communication. How cognitive science can help the health professionals. In: Pharmaceutical Sciences No. 24. Kuopio University Publications, Kuopio.

Maj-Britt Hedvall, Mikael Paltschik. Intrinsic service quality determinants for pharmacy customers. International Journal of Service Industry Management. 1991; 2(2):38–48.

Marmot, M., Wilkinson, R.G.Social determinants of health, 2nd edn. Oxford: Oxford University Press, 2005.

Maslow, A.H. A theory of human motivation. Psychological Review. 1943; 50:370–396.

Maslow, A.H.Motivation and personality. New York: Harper and Row, 1954.

Miller, D.F., Price, J.H.Dimensions of community health, 5th edn. Boston: McGraw-Hill, 1998.

Montagne, M. The Pharmakon Phenomenon: Cultural perceptions of drugs and drug use. In: Davis P., ed. Contested ground – Public purpose and private interest in the regulation of prescription drugs. Oxford: Oxford University Press, 1996.

Panton, R., Chapman, S.Medicines management. London: Pharmaceutical Press, 1998.

Parasuraman, A., Zeithmal, V.A., Beery, L.L. SERVQUAL: A multiple-item scale for measuring consumer perceptions of service quality. Journal of Retailing. 64(1), 1988. [Spring].

Parsons, T. Definitions of health and illness in the light of American values and social structure. In: Jaco E., Gartley E., eds. Patients, physicians and illness: a source book in behavioural science and health, 3rd edn. London: Collier-Macmillan, 1979.

Quick, J.D.Management sciences for health: managing drug supply, 2nd edn. Hartford: Kumarian Press, 1997.

Rogers, E.M.Diffusion of Innovations, 5th edn. New York: Free Press, 1995.

Rose, G. Sick individuals and sick populations. International Journal of Epidemiology. 1985; 14:32–38.

Rosenstock, I. [1966] Historical origins of the health belief model. Health Education Monographs. 1974; 2(4):328–335.

Royal Pharmaceutical Society of Great BritainFrom compliance to concordance: achieving shared goals in medicine taking. London: RPSGB, 1997.

Sarafino, E.P.Health psychology: biopsychosocial interactions, 5th edn. New York: John Wiley, 2005.

Smith, F.J.Research methods in pharmacy practice. London: Pharmaceutical Press, 2002.

Smith, M.C., Knapp, D.A.Pharmacy, drugs and medical care, 5th edn. Baltimore: Williams and Wilkins, 1992.

Smith, M.C., Wertheimer, A.I.Social and behavioural aspects of pharmaceutical care. New York: Pharmaceutical Products Press, 2002.

Taylor, K., Nettleton, S., Harding, G.Sociology for pharmacists, 2nd edn. London: Taylor and Francis, 2003.

Taylor, K.M.G., Nettleton, S., Harding, G.Sociology for pharmacists, 2nd edn. Andover: Taylor and Francis, 2003.

World Health Organization, WHO 1948 Definition of health. Online. Available:<www.who.int/about/definition/en/print.html>.

World Health Organization, WHO 1978 Declaration of Alma-Ata. International Conference on Primary Health Care, Alma-Ata, USSR, 6–12 September. Online. Available:<www.searo.who.int/LinkFiles/Health_Systems_declaration_almaata.pdf>.

World Health Organization, WHO 2003 International conference on Primary healthcare, Alma Ata: 25th anniversary. Report by the Secretariat. WHO Press, Geneva.

Section Two: Protecting the public

Chapter 4: Control of medicines

Department of Health, DoHA review of the prescribing, supply and administration of drugs – a report of the supply and administrations of medicines under group protocols. London: HMSO, 1998.

Department of Health, DoHReview of prescribing, supply and administration of medicines – final report. London: HMSO, 1999.

Department of Health, DHSupplementary prescribing by nurses and pharmacists within the NHS in England: a guide for implementation. London: HMSO, 2005.

Department of Health, DHImproving patients’ access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England. London: HMSO, 2006.

Royal Pharmaceutical SocietyBetter management of minor ailments: using the pharmacist. London: Pharmaceutical Press, 2006.

Chapter 5: Control of health professionals and their staff

General Dental Council. Online. Available:<www.gdc-uk.org>.

General Medical Council. Online. Available:<www.gmc-uk.org>.

Health and Care Professions Council. Online. Available:<www.hcp-uk.org>.

Nursing and Midwifery Council. Online. Available:<www.nmc-uk.org>.

Chapter 6: Continuing professional development and revalidation

Department of Health, DoH, 1998. The new NHS: a first class service. Stationery Office, London.

Department of Health, DHTrust, assurance and safety – the regulation of health professionals in the 21st century. London: HMSO, 2007.

Pharmacists and Pharmacy Technicians Order, 2007. HMSO, London.

Royal Pharmaceutical Society CPD recording site. Online. Available:<www.uptodate.org.uk>.

Wilkie, V. Leadership and management for all doctors. British Journal of General Practice. 2012; 62:230–231.

Chapters 7 and 8: Ethics – the theory and ethics in practice and ethical dilemmas

Aggarwal, R., Bates, I., Davies, J.G., et al. A study of academic dishonesty among students at two schools of pharmacy. Pharmaceutical Journal. 2002; 269:529–533.

Beauchamp, T.L., Childress, J.F.Principles of biomedical ethics, 5th edn. New York: Oxford University Press, 2001.

Belmont Report 1979 Ethical principles and guidelines for the protection of human subjects of research. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 18 April. Online. Available:<www.hhs.gov/ohrp/humansubjects/guidance/belmont_html>.

Benson, A.Pharmacy values and ethics: a qualitative mapping of the perceptions and experiences of UK pharmacy practitioners. Centre for Public Policy, Department of Education and Professional Studies. London: King’s College London, 2006.

Benson, A., Cribb, A., Barber, N.Respect for medicines and respect for people: mapping pharmacist practitioners’ perceptions and experiences of ethics and values. London: Royal Pharmaceutical Society of Great Britain, 2007.

Berwick, D., Davidoff, F., Hiatt, H., et al. Refining and implementing the Tavistock principles for everybody in health care. Commentary: Justice in health care a response to Tavistock. British Medical Journal. 2001; 323:616–620.

British Medical Association, BMACore values of the medical profession in the 21st century – survey report. London: British Medical Association, 1995.

Department of Health, DHWhite Paper: Pharmacy in England. Building on strengths – delivering the future. London: HM Government, 2008.

EthicsWeb.ca. Online. Available:<www.ethicsweb.ca/>(accessed 14 October 2008).

Ethox Centre, Department of Public Health and Primary Health Care, University of Oxford. Online. Available:<www.ethox.org.uk/>(accessed 14 October 2008).

Gillon, R. Medical oaths, declarations, and codes. British Medical Journal. 1985; 290:1194–1195.

Gillon, R.Philosophical medical ethics. Chichester: John Wiley, 1999.

Hawksworth, G. From the president: a personal professional pledge. Pharmaceutical Journal. 2003; 271:849–850.

Hawksworth, G. The president promotes a personal professional pledge for pharmacists. Pharmaceutical Journal. 2004; 272:684–685.

Hawley, G.Ethics in clinical practice: an interprofessional approach. Harlow: Pearson Education, 2007.

Hill, T.E., Zweig, A.Kant: groundwork for the metaphysics of morals. Oxford: Oxford University Press, 2002.

Hope, T., Savulescu, J., Hendrick, J.Medical ethics and law, the core curriculum, 2nd edn. Edinburgh: Churchill Livingstone, 2008.

Hurwitz, B., Richardson, R. Swearing to care: the resurgence in medical oaths. British Medical Journal. 1997; 315:1671–1674.

Internet Encyclopaedia of Philosophy. Online. Available:<www.iep.utm.edu/>(accessed 14 October 2008).

Kennedy Institute of Ethics Georgetown University. Online. Available:<http://bioethics.georgetown.edu/>(accessed 14 October 2008).

Leathard, A., McLaren, S.Ethics: contemporary challenges in health and social care. Bristol: Policy Press, 2007.

Rennie, S.C., Crosby, J.R. Are tomorrow’s doctors honest? A questionnaire study exploring the attitudes and reported behaviour of medical students to fraud and plagiarism. British Medical Journal. 2001; 322:274–275.

Rogers, R., John, D. Paternalism to professional judgement – the history of the code of ethics. Pharmaceutical Journal. 2006; 276:721–723.

Schwartz, L., Preece, P.E., Hendry, R.A.Medical ethics: a case-based approach. Edinburgh: Saunders, 2002.

Smith, R., Hiatt, H., Berwick, D.a. Shared ethical principles for everybody in health care: a working draft from the Tavistock group. British Medical Journal. 1999; 318(7178):248–251.

Smith, R., Hiatt, H., Berwick, D., [Tavistock group]b. A shared statement of ethical principles for those who shape and give health care: a working draft from the Tavistock group. Annals of Internal Medicine. 1999; 130(2):143–147.

Sritharan, K., Russell, G., Fritz, Z., et al. Medical oaths and declarations. British Medical Journal. 2001; 323:1440–1441.

Stanford Encyclopaedia of Philosophy. Online. Available:<http://plato.Stanford.edu/contents.html>(accessed 14 October 2008).

Thimbleby, C.E.H. Drug tariff. Do we have to dispense a prescription item at a loss? Pharmaceutical Journal. 2003; 271:47.

Thompson, M.An introduction to philosophy and ethics. Manchester: Hodder Murray, 2003.

Tonks, A. What’s a good doctor and how do you make one? British Medical Journal. 2002; 325:711.

Vardy, P., Grosch, P.The puzzle of ethics. London: Fount, 1999.

Wingfield, J.a. New emphasis in the code of ethics. Pharmaceutical Journal. 2007; 279:237–240.

Wingfield, J.b. Consent: the heart of patient respect. Pharmaceutical Journal. 2007; 279:411–414.

Wingfield, J.c. When confidences should be kept and what constitutes an exception. Pharmaceutical Journal. 2007; 279:533–536.

Wingfield, J., Badcott, D.Pharmacy ethics and decision making. London: Pharmaceutical Press, 2007.

Chapter 9: Clinical governance

Dean, B. What is clinical governance? Pharmacy in Practice. 2000; 10:182–184.

Department of Health, DH, 1998. A first class service: Quality in the new NHS. Stationery Office, London.

Department of Health, DH, 2000. An organisation with a memory. Stationery Office, London.

Department of Health, DH, 2001. Clinical governance in community pharmacy. Stationery Office, London.

Department of Health, DHBuilding a safer NHS for patients: Improving medication safety. London: DoH, 2004.

NHS, 1999. Clinical Governance in the new NHS. Stationery Office, London.

NHS Executive and National Prescribing Centre, 2000. Competencies for pharmacists working in primary care. Online. Available:<www.npc.co.uk/publications/CompPharm/competencies.htm>.

Royal Pharmaceutical Society of Great Britain, 2000. Pharmacy audit support pack. Online. Available:<www.rpsgb.org/registrationandsupport/audit>.

Royal Pharmaceutical Society of Great Britain, 2005. Scottish Executive 2005 Audit to excellence. CD-ROM. Online. Available:<www.rpsgb.org/registrationandsupport/audit>.

Chapter 10: Risk management

Department of Health, DHAn organisation with a memory: a report from an expert working group on learning from adverse events in the NHS. London: DoH, 2000.

Department of Health, DHBuilding a safer NHS for patients: improving medication safety (a report by the Chief Pharmaceutical Officer). London: DoH, 2004.

National Patient Safety AgencyDesign for patient safety: a guide to the design of the dispensing environment. London: National Patient Safety Agency, 2007.

National Patient Safety AgencybHealthcare risk assessment made easy. London: National Patient Safety Agency, 2007.

National Patient Safety Agency, 2008. Exploring incidents – improving safety: a guide to root cause analysis from the NPSA. E-learning programme. Online. Available:<www.msnpsa.nhs.uk/rcatoolkit/course/iindex.htm>.

Reason, J. Human error: models and management. British Medical Journal. 2000; 320:768–770.

Chapter 11: Standard operating procedures

General Pharmaceutical Council, GPhC, 2010. Guidance for Responsible Pharmacists. Online. Available:<http://www.pharmacyregulation.org/sites/default/files/GPhC%20Responsible%20pharmacist%20guidance.pdf>.

General Pharmaceutical Council, GPhC, 2010. Standards for owners and superintendent pharmacists of retail pharmacy businesses. Online. Available:<http://pharmacyregulation.org/sites/default/files/Standards%20for%20owners%20and%20superintendent%20pharmacist%20of%20retail%20pharmacy%20businesses%20s.pdf>.

National Pharmacy Association, NPAThe NPA guide to standard operating procedures a step-by-step approach for community pharmacy. St Albans: NPA, 2003.

Pharmaceutical Services Negotiating Committee. Tips on Standard Operating Procedures (SOPs). Online. Available:<www.psnc.org.uk>.

Pharmaceutical Society of Northern Ireland. Standards on sale and supply of medicines. Online. Available:<www.psni.org.uk/responsiblepharmacist>.

Chapter 12: Audit

Healthcare Commission National Clinical Audit, 2008. Online. Available:<www.healthcarecommission.org.uk>.

National Institute for Health and Clinical ExcellencePrinciples for best practice in clinical audit. Oxford: Radcliffe Medical Press, 2002.

NHS Clinical Governance Support Team, 2005. A practical handbook for clinical audit. Online. Available:<www.cgsupport.nhs.uk/downloads/Practical_Clinical_Audit_Handbook_vl_l.pdf>.

Royal Pharmaceutical Society of Great Britain Clinical Audit Unit. Online. Available:<www.rpsgb.org/registrationandsupport/audit/>(accessed 14 October).

Chapter 13: Public health

Acheson D. 1998. Independent inquiry into inequalities in health: report. Stationery Office, London.

Dahlgren, G., Whitehead, M.Policies and strategies to promote social equity in health. Stockholm: Institute of Future Studies, 1991.

Department of Health, 2004. Choosing health: making healthy choices easier. Stationery Office, London. Online. Available:<www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH>4094550.

Department of Health, 2005. Choosing health through pharmacy: a programme for pharmaceutical public health 2005–2015. Stationery Office, London. Online. Available:<www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4107494>.

Marmot, M.G., Shipley, M.J., Rose, G. Inequalities in death: specific explanations of a general pattern. Lancet I. 1984; 1003–1006.

Marmot, M.G., Davey Smith, G., et al. Health inequalities among British civil servants: the Whitehall II study. Lancet. 1991; 337:1387–1393.

NHS Health Scotland, 2004. Online. Available:<www.healthscotland.com>.

Walker, R. Pharmaceutical public health: the end of pharmaceutical care? Pharmaceutical Journal. 2000; 264:340–341.

Section Three: Delivering professional pharmacy practice

Chapter 14: Structure and organization of pharmacy

British National Formulary, BNF. Online. Available:<www.bnf.org/>.

British Pharmacopeia Commission. British Pharmacopeia. Online. Available:<www.pharmacopoeia.co.uk/>.

NHS Careers, Working as a hospital pharmacist. Online. Available:<www.nhscareers.nhs.uk/explore-by-career/pharmacy-careers/pharmacist/hospital-pharmacist/>.

NHS The NHS in England. The NHS structure explained. Online. Available:<www.nhs.uk/NHSEngland/thenhs/about/Pages/nhsstructure.aspx>.

Pharmaceutical Services Negotiating Committee. Online. Available:<www.psnc.org.uk/pages/about_community_pharmacy.html>.

Royal Pharmaceutical Society. Online. Available:<www.rpharms.com>.

Chapter 16: Information retrieval in pharmacy practice

Allwood M., Stanley A.P., Wright P., eds. The cytotoxics handbook, 4th edn. Oxford: Radcliffe Medical Press, 2002.

Anon. An introduction to assessing medical literature. MeReC Briefing. 1995; 9:1–8.

Applebe, G.E., Wingfield, J.Dale and Applebe’s pharmacy law and ethics. London: Pharmaceutical Press, 2009.

Aronson, J.K., Dukes, M.N.G.Meyler’s side-effects of drugs: the international encyclopedia of adverse drug reactions and interactions, 15th edn. Amsterdam: Elsevier, 2006.

Ashley, C., Currie, A.The renal drug handbook. Oxford: Radcliffe Medical Press, 2009.

Baxter, K.Stockley’s drug interactions, 8th edn. London: Pharmaceutical Press, 2007.

Brazier, H., McCabe, G. Making the most of Medline. Hospital Medicine. 1998; 59(10):756–761.

Covell, D.G., Uman, G.C., Manning, P.R. Information needs in office practice: are they being met? Annals of Internal Medicine. 1985; 103:596–599.

Ely, J.W., Osheroff, J.A., Bell, M.H., et al. Analysis of questions asked by family doctors regarding patient care. British Medical Journal. 1999; 319:358–361.

Ely, J.W., Osheroff, J.A., Ebell, M.H., et al. Obstacles to answering doctors’ questions about patient care with evidence: qualitative study. British Medical Journal. 2002; 324:710–713.

Gardner, M. Information retrieval for patient care. British Medical Journal. 1997; 314:950–954.

Gray, A., Wright, J., Goodey, V., et alInjectable drugs guide. London: Pharmaceutical Press, 2011.

Greenhalgh, T. Assessing the methodological quality of published papers. British Medical Journal. 1997; 315:305–308.

Guillebaud J. Contraception: your questions answered. Churchill Livingstone, Edinburgh.

Hands, D., Judd, A., Golightly, P., et al. Drug information and advisory services – past, present and future. Pharmaceutical Journal. 1999; 262:160–162.

Impicciatore, P., Pandolfini, C., Casella, N., et al. Reliability of health information for the public on the world wide web: systematic survey of advice on managing fever in children at home. British Medical Journal. 1997; 314:1875–1881.

Kumar, P.J., Clark, M.L.Clinical medicine. Oxford: Elsevier, 2012.

McRibbon, K.A., Wilczynski, N.L., Walker-Dilks, C.J. How to search for and find evidence about therapy. Evidence-Based Medicine. 1996; 1(3):70–72.

Malone, P. Drug information technology and Internet resources. Journal of Pharmacy Practice. 1998; 11:196–218.

Mason, P.Dietary Supplements. London: Pharmaceutical Press, 2011.

Morgan D. 2010. Formulary of Wound Management Products. Euromed Communications, Surrey.

North-Lewis, P.Drugs and the liver: a guide to drug handling in liver dysfunction. London: Pharmaceutical Press, 2008.

Porter, R.S.Merck manual of diagnosis and therapy. West Point: Merck and Co, 2008.

Regnard, C.F.B., Dean, M.A guide to symptom relief in palliative care. Oxford: Radcliffe Medical Press, 2010.

Rubin, P., Ramsay, M.Prescribing in pregnancy. Oxford: Blackwell, 2007.

Schaefer, C., Peters, P.W.J., Miller, R.K.Drugs during pregnancy and lactation. Edinburgh: Elsevier, 2007.

Shaughnessy, A.F., Slawson, D.C., Bennett, J.H. Becoming an information master: a guidebook to the medical information jungle. Journal of Family Practice. 1994; 39:489–499.

Slawson, D.C., Shaughnessy, A.F. Obtaining useful information from expert based sources. British Medical Journal. 1997; 314:947–949.

Slawson, D.C., Shaughnessy, A.F., Bennett, J.H. Becoming a medical information master: feeling good about not knowing everything. Journal of Family Practice. 1994; 39:505–513.

Smith, R. What clinical information do doctors need? British Medical Journal. 1996; 313:1062–1068.

Straus, S.E., Glasziou, P., Richardson, W.S., et alEvidence-based medicine: how to practice and teach it. Edinburgh: Churchill Livingstone, 2011.

Sweetman, S.C.Martindale: the complete drug reference. London: Pharmaceutical Press, 2011.

Taylor, D., Paton, C., Kapur, R.Maudsley prescribing guidelines in psychiatry. Oxford: Blackwell, 2012.

Walker, R., Whittlesea, C.Clinical pharmacy and therapeutics, 5th edn. Edinburgh: Churchill Livingstone, 2007.

Williamson, E.M., Driver, S., Baxter, K.Stockley’s herbal medicines interactions: a guide to the interactions of herbal medicines. London: Pharmaceutical Press, 2013.

Winter, M.E.Basic clinical pharmacokinetics. London: Lippincott Williams & Wilkins, 2009.

Wright, S.G., LeCroy, R.L., Kendrach, M.G. A review of the three types of biomedical literature and the systematic approach to answer a drug information request. Journal of Pharmacy Practice. 1998; 11:148–162.

Chapter 17: Communication skills for pharmacists and their team

Argyle, M.The psychology of interpersonal behaviour, 4th edn. Harmondsworth: Penguin, 1983.

Beardsley, R.S., Kimberlin, C.L., Tindall, W.N.Communication skills in pharmacy practice, 5th edn. Baltimore: Lippincott Williams & Wilkins, 2007.

Burnard, P.Effective communication skills for health professionals, 2nd edn. London: Chapman and Hall, 1997.

Dickson, D., Hargie, O., Morrow, N.Communication skills training for health professionals, 2nd edn. London: Chapman and Hall, 1997.

Kurtz, S.M., Silverman, J.D. The Calgary-Cambridge referenced observation guides: an aid to defining the curriculum and organizing the teaching in communication training programmes. Medical Education. 1996; 30(2):83–89.

Ley, P.Communicating with patients. London: Croom Helm, 1988.

Pease, B., Pease, A.The definitive book of body language. Atlanta: Bantam Books, 2006.

U.S. Pharmacopeia Medication counseling behaviour guidelines. Online. Available:<www.usp.org>.

Chapter 18: Concordance

Berry, D.Risk, Communication and Health Psychology. Maidenhead: Open University Press, 2004.

Bond C., ed. Concordance – a partnership in medicine taking. London: Pharmaceutical Press, 2004.

Britten, N., Stevenson, F.A., Barry, C.A., et al. Misunderstandings in prescribing decisions in general practice: qualitative study. British Medical Journal. 2000; 320:484–488.

Chewning, B., Bylund, C.L., Shah, B., et al. Patient preferences for shared decisions: a systematic review. Patient Education and Counseling. 2012; 86:9–18.

Clyne W., Granby T., Picton C. 2007 A competency framework for shared decision-making with patients – achieving concordance for taking medicines. Keele: NPC Plus; January. Online. Available:<www.npc.nhs.uk/non_medical/resources/competency_framework_2007.pdf>.

Coulter, A. Partnerships with patients: the pros and cons of shared clinical decision-making. Journal of Health Services Research and Policy. 1997; 2:112–121.

Coulter, A., Ellins, J., Swain, D., et alAssessing the quality of information to support people in making decisions about their health and healthcare. Oxford: The Picker Institute, 2006.

General Pharmaceutical CouncilStandards of conduct, ethics and performance. London: GPhC, 2010.

Gigerenzer, G., Edwards, A. Simple tools for understanding risks: from innumeracy to insight. British Medical Journal. 2003; 327:741–744.

Haynes R.B., Montague P. Oliver T. et al. 2001 Interventions for helping patients to follow prescriptions for medications (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford Update Software, Oxford.

Joosten, E.A.G., De-Fuentes-Merillas, L., de Weert, G.H., et al. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychotherapy and Psychosomatics. 2008; 77:219–226.

Kurtz, S., Silverman, J.D., Bendon, J., et al. Marrying Content and Process in Clinical Method Teaching: Enhancing the Calgary-Cambridge Guides. Academic Medicine. 2003; 78:802–809.

Lewin, S.A., Skea, Z.C., Entwistle, V., et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database of Systematic Reviews. (4):2001.

Marinker M., Blenkinsopp A., Bond C. et al. 1997. From Compliance to Concordance – achieving shared goals in medicine taking. A joint report by the Royal Pharmaceutical Society of Great Britain and Merck, Sharpe & Dohme. Royal Pharmaceutical Society, London.

National Institute for Health and Clinical ExcellenceMedicines adherence: involving patients in decisions about prescribed medicines and supporting adherence (CG76). London: NICE, 2009.

O’Connor, A.M., Stacey, D., Entwistle, V., et al. Decisions aids for people facing health treatment or screening decisions. Cochrane Database Systematic Review. (1):2003.

Ottawa Health Research Institute 2007 Patient Decision Aids. Online. Available:<http://decisionaid.ohri.ca/index.html>12 August.

Raynor, D.K., Blenkinsopp, A., Knapp, P., et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technology Assessment. 2007; 11:5.

Simpson, S.H., Eurich, D.T., Majumdar, S.R., et al. A meta-analysis of the association between adherence to drug therapy and mortality. British Medical Journal. 2006; 333:15.

Stevenson, F.A., Cox, K., Britten, N., et al. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expectations. 2004; 7:235–245.

Stewart, M.A. Effective physician-patient communication and health outcomes: a review. Canadian Medical Association Journal. 1995; 152:1423–1433.

Weiss, M.C. The informed patient: friend or foe? Pharmaceutical Journal. 2007; 278:143–146.

Weiss, M.C., Britten, N. What is concordance? Pharmaceutical Journal. 2003; 271:493.

Chapter 19: Pharmaceutical calculations

Ansel, H.C.Pharmaceutical calculations, 13th edn. Baltimore: Lippincott Williams & Wilkins, 2009.

Rees, J.A., Smith, I., Smith, B.Introduction to pharmaceutical calculations, 3rd edn. London: Pharmaceutical Press, 2010.

Smith, I., Rees, J.A.Pharmaceutical calculations workbook. London: Pharmaceutical Press, 2005.

Winfield, A.J., Edafiogho, I.E.Calculations for pharmaceutical practice. Edinburgh: Churchill Livingstone, 2005.

Section Four: Access to medicines and their selection

Chapter 20: The prescribing process and evidence-based medicine

Barber, N. What constitutes good prescribing? British Medical Journal. 1995; 310:923–925.

Department of HealthImproving patients’ access to medicines: A guide to implementing nurse and pharmacist independent prescribing within the NHS in England. London: HMSO, 2006.

Eccles, M., Freemantle, N., Mason, J. North of England evidence-based guideline development project. British Medical Journal. 1998; 317:526–530.

MeReC. Evidence based medicine. MeReC Bulletin. 1995; 6(12):45–48.

National Prescribing CentreA single competency framework for all prescribers. London: NPC, 2012.

Chapter 21: Prescribing for minor ailments

Briggs, G.G., Freeman, R.K., Yaffe, S.J.Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 8th edn. Philadelphia: Lippincott Williams & Wilkins, 2008.

Chapter 22: Drug evaluation and pharmacoeconomics

Briggs, A.H., O’Brien, B.J. The death of cost-minimization analysis? Health Economics. 2001; 10:179–184.

Drummond, M.F., Sculpher, M.J., Torrance, G.W., et alMethods for the economic evaluation of health care programmes, 3rd edn. Oxford: Oxford University Press, 2005.

Elliot, R., Payne, K.Essentials of economic evaluation in healthcare. London: Pharmaceutical Press, 2004.

Heart Protection Study Collaborative Group. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomized trial in 20,536 individuals. Lancet. 2005; 365:1779–1785.

Hughes, D.A. Modelling in health economics. In: Walley T., Haycox A., Boland A., eds. Pharmacoeconomics. Edinburgh: Churchill Livingstone, 2004.

Hughes, D.A., Vilar, F.J., Ward, C.C., et al. Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics. 2004; 14(6):335–342.

Lowson, K.V., Drummond, M.F., Bishop, J.M. Costing new services: long-term domiciliary oxygen therapy. Lancet. 1981; 1(8230):1146–1149.

National Institute for Health and Clinical Excellence 2004 Guide to the methods of technology appraisal. Prescribing Support Unit. Online. Available:<www.ic.nhs.uk/services/prescribing-support-unit-psu>.

Scottish Intercollegiate Guidelines Network 2008 SIGN Guideline 50. A guideline developer’s handbook, revised edn. Online. Available:<www.sign.ac.uk/guidelines/fulltext/50/index.html>(accessed 14 October 2008).

Scottish Medicines Consortium. Online. Available:<www.scottishmedicines.org.uk/smc>.

Walley, T., Haycox, A., Boland, A.Pharmacoeconomics. Edinburgh: Churchill Livingstone, 2003.

Chapter 23: Formularies in pharmacy practice

Cambridgeshire Primary Care Trust Formulary, latest update. Online. Available:<www.cambsphn.nhs.uk/default.asp?id=149>(accessed 14 October 2008).

Central Services Agency Northern Ireland COMPASS therapeutic notes. Online. Available:<www.centralservicesagency.com/display/compass>(accessed 14 October 2008).

Furniss L. 2000 Formularies in primary care. Primary Care Pharmacy 1(2): 37–39. Online. Available:<www.pharmj.com/PrimaryCarePharmacy/200003/medicines/formularies.html>(accessed 14 October 2008).

Health Solutions Wales. Online. Available:<www.hsw.wales.nhs.uk/page.cfm?orgid=166&pid=3997>(accessed 14 October 2008).

Information Services Division (Scotland). Online. Available:<www.isdscotland.org/isd/1038.html>(accessed 14 October 2008).

Lothian Joint Formulary. Online. Available:<www.ljf.scot.nhs.uk/>(accessed 14 October 2008).

National Prescribing Centre 2007 Managing medicines across a health community: making area prescribing committees fit for purpose. NHS Tayside Area Prescribing Guide (TAPG). Online. Available:<www.nhstaysideadtc.scot.nhs.uk/approved/formular/formular.htm>.

National Institute for Health and Clinical Excellence December, 2012. Developing and updating local formularies Available at:<www.nice.org.uk/mpc/goodpracticeguidance/GPG1.jsp>(accessed February 2013).

Pegler S. 2007 Whatever the appeal of drug lunches, take STEPS to avoid indigestion! Pharmaceutical Journal 278: 612–614 Online. Available:<www.pharmj.com/pdf/articles/pj_20070526_steps.pdf>.

Prescribing Support Unit Items. Measures of prescribing: Online. Available:<www.ic.nhs.uk/services/prescribing-support-unit-psu/measures>.

Prescribing Indicators. Online. Available:<www.ic.nhs.uk/our-services/prescribing-support-unit/indicators>.

Prescription Pricing Division (England). Online. Available:<www.ppa.org.uk/index.htm>. (accessed 14 October 2008).

Twycross, R., Wilcock, A., Charlesworth, S., et alPalliative care formulary, 2nd edn. Oxford: Radcliffe Publishing, 2002.

Chapter 24: Complementary and alternative medicine

Ang-Lee, M.K., Moss, J., Yuan, C.-S. Herbal medicines and perioperative care. Journal of the American Medical Association. 2001; 286:208–216.

Barnes, J., Anderson, L.A., Phillipson, J.D.Herbal medicines. A guide for healthcare professionals, 3rd edn. London: Pharmaceutical Press, 2007.

Commission of the European CommunitiesProposal for amending the directive 2001/83/EC as regards traditional herbal medicinal products. Brussels: The European Commission, 2002/0008.

Department of Health, 2001. Government response to the House of Lords Select Committee on Science and Technology’s report on complementary and alternative medicine. Stationery Office, London.

Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Online. Available:<http://europa.eu.int/eur-lex/lex/LexUriServ/LexUriServ.do?uri=CELEX:32004L0024:HTML>, EN.

Eisenberg, D.M., Davis, R.B., Ettner, S.L., et al. Trends in alternative medicine use in the United States, 1990–1997. Results of a national follow-up survey. Journal of the American Medical Association. 1998; 280:1569–1575.

Ernst, E., White, A. The BBC survey of complementary medicine use in the UK. Complementary Therapies in Medicine. 2000; 8:32–36.

Gunther, S., Patterson, R.E., Kristal, A.R., et al. Demographic and health-related correlates of herbal and specialty supplement use. Journal of the American Dietetic Association. 2004; 104(1):27–34.

House of Lords Select Committee on Science and Technology, 2000. Session 1999–2000, 6th report. Complementary and alternative medicine. Stationery Office, London.

Kayne, S.Complementary therapies for pharmacists. London: Pharmaceutical Press, 2002.

MCA (Now MHRA), 2002. Safety of herbal medicinal products, July. Online. Available:<http://64.233.183.104/search?q=cache>: DYdaAUqZ2P4J:<www.mhra.gov.uk/home/idcplg%3FIdcService%3DGET_FILE%26dID%3D665%26noSaveAs%3D0%26Rendition%3DWEB+safety+of+herbal+medicinal+products&hl=en&ct=clnk&cd=2&gl=u>(accessed 14 February 2007).

Mills S., Peacock W. 1997 Professional organisation of complementary and alternative medicines in the United Kingdom 1997. A report to the Department of Health. University of Exeter, Exeter.

Mintel Oxygen 2009 Complementary Medicines Market, UK.

Thomas, K.J., Nicholl, J.P., Coleman, P. Use and expenditure on complementary medicine in England: a population based survey. Complementary Therapies in Medicine. 2001; 9:2–11.

Traditional ethnic medicines, 2001. Public health and compliance with medicines law. London: Medicines Control Agency. Online. Available:<www.mca.gov.uk>.

UK Government. The Medicines for Human Use (Marketing Authorisations, etc.) Regulations (S1 1994/3144) 1994. Stationery Office, London.

UK Government. The Medicines for Human Use (Marketing Authorisations, etc.) Amendment Regulations (S1 2000/292) 2000. Stationery Office, London.

UK Government. The Medicines for Human Use (Marketing Authorisations, etc.) Amendment Regulations (S1 2005/768) 2005. Stationery Office, London.

UK Government. The Medicines (Aristolochia and Mu Tong etc.) (Prohibition) Order (S1 2001/1841) 2001. Stationery Office, London.

Zollman, C., Vickers, A. What is complementary medicine? British Medical Journal. 1999; 319:693–696.

Chapter 25: Communication skills: advice and information on the selection of medicines

Beardsley, R.S., Kimberlin, C.L., Tindall, W.N.Communication skills in pharmacy practice, 5th edn. Baltimore: Lippincott Williams & Wilkins, 2007.

Dickson, D., Hargie, O., Morrow, N.Communication skills training for health professionals, 2nd edn. London: Chapman and Hall, 1997.

Egan, G.The Skilled Helper, 4th edn. Pacific Grove: Brooks/Cole, 1990.

Ley, P.Communicating with patients. London: Croom Helm, 1988.

Tindall, W.N., Beardsley, R.S., Kimberlin, C.L.Communication skills in pharmacy practice, 4th edn. Baltimore: Lippincott Williams & Wilkins, 2002.

U.S. Pharmacopeia Medication Counseling Behaviour Guidelines. Online. Available:<www.usp.org>(accessed 15 October 2008).

Chapter 26: Patient charges for medicines and their impact on access

Austvoll-Dahlgren, A., Aaserud, M., Vist, G., et al. Pharmaceutical policies: Effects of cap and co-payment on rational drug use. Cochrane Database of Systematic Reviews. (1):2008.

Cox, E.R., Henderson, R.R. Prescription use behaviour among Medicare beneficiaries with capped prescription benefits. Journal of Managed Care Pharmacy. 2002; 8:360–364.

Cox, E.R., Jernigan, C., Joel Coons, S.J., et al. Medicare beneficiaries’ management of capped prescription benefits. Medical Care. 2001; 39:296–301.

Lexchin, J., Grootendorst, P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. International Journal of Health Services. 2004; 34:101–122.

Rice, T., Matsuoka, K.Y. The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors. Medical Care Research and Review. 2004; 61:415–452.

Safran, D.G., Neuman, P., Schoen, C., et al. Prescription drug coverage and seniors: Findings from a 2003 national survey. Health Affairs Web Exclusive. 2005; W5(April):152–166.

Schafheutle, E.I. The impact of prescription charges on asthma patients is uneven and unpredictable: evidence from qualitative interviews. Primary Care Respiratory Journal. 2009; 18:266–272.

Schafheutle, E.I., Hassell, K., Noyce, P.R. Coping with prescription charges in the UK. International Journal of Pharmacy Practice. 2004; 12:239–246.

Schafheutle, E.I., Hassell, K., Noyce, P.R., et al. Access to medicines: cost as an influence on the views and behaviour of patients. Health and Social Care in the Community. 2002; 10:187–195.

Soumerai, S.B., McLaughlin, T.J., Ross-Degnan, D., et al. Effect of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine. 1994; 331:650–655.

Tamblyn, R., Laprise, R., Hanley, J.A., et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. Journal of the American Medical Association. 2001; 285:421–429.

Weiss, M.C., Hassell, K., Schafheutle, E.I., et al. Strategies used by General Practitioners to minimise the impact of the prescription charge. European Journal of General Practice. 2001; 7:23–26.

Chapter 27: The prescription

Department of HealthReview of prescribing supply and administration of medicines. Initial report (Crown review). London: Department of Health, 1998.

Department of HealthReview of prescribing supply and administration of medicines. Final report (Crown review). London: Department of Health, 1999.

Drug tariff, current edition. Stationery Office. Online. Available:<www.ppa.org.uk/ppa/edt_intro.htm>(accessed 16 October 2008).

Editorial. Consultation on SOPs for dispensing. Pharmaceutical Journal. 2001; 266:616–619.

National Prescribing Centre. Signposts for prescribing nurses. Prescribing Nurse Bulletin. 1999; 1(1):1–4.

Chapter 28: Veterinary pharmacy

British Small Animal Veterinary Association. Online. Available:<www.bsava.com>.

British Veterinary Association. Online. Available:<www.bva.co.uk>.

Food Standards Agency. Online. Available:<www.food.gov.uk/business-industry/farmingfood/vetmeds/>.

Health and Safety Executive. Online. Available:<www.hse.gov.uk>.

Kahn, C.M., Line, S.The Merck veterinary manual, 9th edn. London: Merck, 2005.

National Office of Animal Health. Online. Available:<www.noah.co.uk>.

Pharmaceutical Society of Northern Ireland. The Veterinary Medicines Regulations Medicines for Veterinary Use.

Royal Pharmaceutical Society, including the Veterinary Pharmacists’ Group. Online. Available:<www.rps.org.uk>.

Veterinary Medicines Directorate. Online. Available:<www.vmd.defra.gov.uk>.

Section Five: Medicines and their preparation

Chapter 31: Labelling of dispensed medicines

Information leaflet pictograms. Online. Available:<www.fip.org/pictograms>.

Chapter 32: Packaging

Royal Pharmaceutical Society. Working Party Report. Labelling of dispensed medicines. Pharmaceutical Journal. 1990; 245:128–129.

Chapter 33: Solutions

Diluent directories (internal and external), current edition. National Pharmaceutical Association, NPA, St Albans.

Chapter 36: External preparations

Benson, H.A.E., Watkinson, A.C.Topical and transdermal drug delivery: principles and practice. Hoboken: Wiley-Blackwell, 2012.

Walters, K.A., Roberts, M.S.Dermatologic, cosmeceutic, and cosmetic development: therapeutic and novel approaches: absorption efficacy and toxicity. New York: Informa Healthcare, 2007.

Williams, A.C.Transdermal and topical drug delivery. London: Pharmaceutical Press, 2003.

Chapter 37: Suppositories and pessaries

Allen, L.V.Suppositories. London: Pharmaceutical Press, 2007.

Pharmaceutical Society of Great BritainPharmaceutical handbook, 19th edn. London: Pharmaceutical Press, 1980.

Chapter 39: Oral unit dosage forms

Podczeck, F., Jones, B.Pharmaceutical capsules, 2nd edn. London: Pharmaceutical Press, 2004.

Section Six: Specialized pharmacy products and services

Chapter 40: Production of sterile products

Beaney, A.M.Quality assurance of aseptic preparation service, 4th edn. London: Pharmaceutical Press, 2005.

European Commission, The rules governing medicinal products in the European Union. EU guidelines to good manufacturing practice for medicinal products for human and veterinary use; Vol IV. European Commission, Brussels, 2005.

MHRARules and guidance for pharmaceutical manufacturers and distributors 2007 – the ‘Orange guide’. London: Pharmaceutical Press, 2007.

Midcalf, B., Phillips, M., Neiger, J.S., et alPharmaceutical isolators. London: Pharmaceutical Press, 2004.

Chapter 41: Parenteral products

Akers, M.J., Larrimore, D.S., Guazzo, D.M.Parenteral quality control: sterility, pyrogens, particulate and package integrity testing, 3rd edn. New York: Marcel Dekker, 2002.

Avis K.E., Lieberman H.A., Lachman L., eds. Pharmaceutical dosage forms: parenteral medications, Vol. 1, 2nd edn. New York: Marcel Dekker, 1992.

British Standards Institute 1989 British Standard 2463, Part 2. British Standards Institute, London.

British Standards Institute 2004 BS EN ISO 1135–1134: 2004. British Standards Institute, London.

Collentro, W.V.Pharmaceutical water: systems design, operation and validation, 2nd edn. Buffalo Grove: Interpharm Press, 2008.

DeLuca, P.P., Boylan, J.C. Formulation of small volume parenterals, 2nd edn. In: Avis K.E., Lieberman H.A., Lachman L., eds. Pharmaceutical dosage forms: parenteral medications. New York: Marcel Dekker, 1992.

Demorest, L.J., Hamilton, J.G. Formulation of large volume parenterals, 2nd edn. In: Avis K.E., Lieberman H.A., Lachman L., eds. Pharmaceutical dosage forms: parenteral medications. New York: Marcel Dekker, 1992.

Levchuk, J.W. Parenteral products in hospital and home care pharmacy practice, 2nd edn. In: Avis K.E., Lieberman H.A., Lachman L., eds. Pharmaceutical dosage forms: parenteral medications. New York: Marcel Dekker, 1992.

Pharmaceutical codexSolution properties, 12th edn. London: Pharmaceutical Press, 1994. [pp. 49–67].

Turco, S.Sterile dosage forms: their preparation and clinical application, 4th edn. Baltimore: Lippincott Williams & Williams, 1994.

Williams, K.L.Endotoxins, pyrogens, LAL testing and depyrogenation, 2nd edn. New York: Marcel Dekker, 2001.

Chapter 42: Ophthalmic products

Royal Pharmaceutical Society. Guidance for use of ophthalmic preparations in hospital and care homes. Pharmaceutical Journal. 2001; 267:307.

Chapter 43: Inhaled route

ABPI compendium of patient information leaflets current edition. Datapharm, London.

BTS/SIGN Asthma Guideline 2011 (January 2012 revision). Online. Available:<www.brit-thoracic.org.uk/guidelines/asthma-guidelines.aspx>.

EMC Medicines. Electronic medicines compendium. Online. Available:<http://emc.medicines.org.uk>.

Murphy, A.Asthma in focus. London: Pharmaceutical Press, 2006.

National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease. Online. Available:<http://guidance.nice.org.uk>.

National Prescribing Centre. Chlorofluorocarbon (CFC) free inhalers. MeReC Bulletin. 1998; 9(5):17–20.

NICE CG101. Chronic Obstructive Pulmonary Disease. Online. Available:<http://guidance.nice.org.uk/CG101/NICEGuidance/pdf/English>.

Purewal, T.S., Grant, D.J.W.Metered dose inhaler technology. Buffalo Grove, IL: Interpharm Press, 2002.

SIGN Guideline British guideline on the management of asthma. Online. Available:<www.sign.ac.uk/guidelines>.

Chapter 44: Parenteral nutrition and dialysis

Ashley, C., Currie, A., Renal, U.K., Pharmacy Group, UKRPGThe renal drug handbook, 3rd edn. Oxford: Radcliffe Medical Press, 2009.

Ashley, C., Morlidge, C., Renal, U.K., Pharmacy Group, UKRPGIntroduction to renal therapeutics. London: Pharmaceutical Press, 2008.

Austin, P., Stroud, M.Prescribing adult intravenous nutrition. London: Pharmaceutical Press, 2007.

Walker, R., Edwards, C.Clinical pharmacy and therapeutics, 3rd edn. Edinburgh: Churchill Livingstone, 2003.

Wood, S.Home parenteral nutrition: quality criteria for clinical services and the supply of nutrient fluids and equipment. Maidenhead: British Association for Parenteral and Enteral Nutrition, 1995.

Chapter 45: Radiopharmacy

Sampson C.B., ed. Textbook of radiopharmacy: theory and practice, 3rd edn. Amsterdam: Gordon and Breach Science, 1999.

Chapter 46: Specialized services

Allwood M., Stanley A.P., Wright P., eds. The cytotoxics handbook, 4th edn. Oxford: Radcliffe Medical Press, 2002.

Beaney, A.M., (formerly from NHS Quality Control Committee)The quality assurance of aseptic services, 4th edn. London: Pharmaceutical Press, 2006.

British Oncology Pharmacy Association. Position statement on care of patients receiving oral anticancer drugs. Pharmaceutical Journal. 2004; 272:423–424.

Department of Health and Social Security 1976 Breckenridge working party: report of the working party on addition of drugs to intravenous infusion fluids. HC (76)9. HMSO, London.

International Society of Oncology Pharmacy Practitioners (ISOPP) Guidelines on safe handling and other information. Online. Available:<www.isopp.org>.

Management and Awareness of Risks of Cytotoxic Handling (MARCH) guidelines. Online. Available:<www.marchguidelines.com>.

Needle, R.A. Survey of hospital centralized intravenous additive services. Pharmaceutical Journal. 1995; 225:326–327.

Needle, R.A.CIVAS handbook. London: Pharmaceutical Press, 2007.

Pharmaceutical Society. Working party report: guidelines for the handling of cytotoxic drugs. Pharmaceutical Journal. 1983; 230:230–231.

Society of Hospital Pharmacists of Australia. Standards of practice for the provision of oral chemotherapy for the treatment of cancer. Journal of Pharmacy Practice and Research. 2007; 37:147–150.

Trissel, L.A.Handbook on injectable drugs, 14th edn. Bethesda: American Society of Health-System Pharmacists, 2006.

Section Seven: Pharmacy services

Chapter 48: Public health and pharmacy interventions

Fraser Guidelines. Online. Available:<www.gpnotebook.co.uk>.

National Pharmacy Association. Online. Available:<www.npa.co.uk>.

Pharmaceutical Services Negotiating Committee. Online. Available:<www.psnc.org.uk>.

Royal Pharmaceutical Society. Online. Available:<www.rpharms.com>.

Chapter 49: Pharmacy services for vulnerable patients

Department of HealthNo Secrets: Guidance on developing and implementing multi-agency policies and procedures to protect vulnerable adults from abuse. London: DH, 2000.

Department of HealthNational Service Framework for older people. London: DH, 2001.

Department of Health, 2001. The Bristol Royal Infirmary Inquiry Report. London: The Stationery Office Limited.

Department of HealthNational Service Framework for children young people and maternity services. London: DH, 2004.

Department for Education, 2010. First and Second Serious Case Review Reports relating to Peter Connelly (‘Baby P’). London: Haringey Local Safeguarding Children Board. Online. Available:<www.education.gov.uk>.

Department of Health (updated 2010). Working together to safeguard children: A guide to inter-agency working to safeguard and promote the welfare of children. DH, London.

Department of HealthSafeguarding adults: The role of health service practitioners. London: DH, 2011.

Department of Health (regular updates). The green book. DH, London.

House of Commons Health Committee, 2003. The Victoria Climbié Inquiry Report. London: The Stationery Office Limited. Online. Available:<www.publications.parliament.uk>.

Royal Pharmaceutical Society, 2011. Protecting vulnerable adults a professional practice quick reference guide.

Royal Pharmaceutical Society, 2011. Protecting children and young people a professional practice quick reference guide.

UK Government‘Who decides?’, Consultation paper. London: Lord Chancellor’s Department, 1997.

Chapter 50: Substance use and misuse

Berridge, V., Edwards, G.Opium and the people, 2nd edn. London: Free Association Books, 1998.

Department of Health (England) and the devolved administrations (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive. Online. Available:<www.nta.nhs.uk/uploads/clinical_guidelines_2007.pdf>.

Driver and Vehicle Licensing Agency At a glance guide to medical aspects of fitness to drive. DVLA, Swansea, 2008. Online. Available:<www.dvla.gov.uk./medical/ataglance>. aspx (accessed 15 October 2008)

DrugScope U.K. charity. Supporting professionals. Online. Available:<www.drugscope.org.uk/>

Gelder, M., Mayou, R., Harrison, P.Misuse of alcohol and drugs. The shorter Oxford textbook of psychiatry, 5th edn. Oxford: Oxford University Press, 2006.

Gossop, M.Living with drugs, 6th edn. Aldershot: Ashgate, 2007.

Gossop M., Marsden J., Stewart D. 2001. NTORS (National Treatment Outcome Research Study) after five years: changes in substance use, health and criminal behaviour during the five years after intake.

Home Office 2010 Current strategy. Online. Available:<www.homeoffice.gov.uk/drugs/drug-strategy-2010>.

Ksobiech, K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention. 2003; 15(3):257–268.

MacDonald, M., Law, M., Kaldor, J., et al. Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy. 2003; 14:353–357.

Mathei, C., Shkedy, Z., Denis, B., et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. Journal of Viral Hepatitis. 2006; 13(8):560–570.

National Addiction Centre (Crown copyright), London. Online. Available:<www.erpho.org.uk/Download/Public/5367/1/ntors5yr.pdf>(accessed 15 October 2008).

National Treatment Agency publication Best Practice Guidance for Commissioners and Providers of Pharmaceutical Services for Drug Users (February 2006). Online. Available:<www.nta.nhs.uk/uploads/nta_best_practice_pharma_services_for_drug_users_pharmguide06.pdf>.

Neale, J. Drug users’ views of substitute prescribing conditions. International Journal of Drug Policy. 1999; 10:247–258.

Release: Drugs the Law and Human Rights. Online. Available:<www.release.org.uk/>.

Roberts, K., Bryson, S.M. The contribution of Glasgow pharmacists to the management of drug misuse. Hospital Pharmacist. 1999; 6:244–248.

Sheridan, J., Strang, J.Drug misuse and community pharmacy. Andover: Taylor and Francis, 2002.

Stimson, G.V., Des Jaríais, D.C., Ball, A.Drug injecting and HIV infection. London: Taylor and Francis, 1998.

The Alliance. Online. Available:<www.m-alliance.org.uk>

Walker, M. Shared care of opiate misusers in Berkshire. Pharmaceutical Journal. 2001; 266:547–552.

Ward, J., Hall, W., Mattick, R. Role of maintenance treatment in opioid dependence. Lancet. 1999; 353:221–226.

Wills, S.Drugs of abuse, 2nd edn. London: Pharmaceutical Press, 2005.

World Health Organization, Expert Committee on Drug Dependence34th Report. Geneva: WHO, 2007.

World Health Organization 2010 Online. Available:<http://apps.who.int/classifications/icd10/browse/2010/en#>.

Chapter 51: Monitoring the patient

MHRA Black Triangle list. Online. Available:<www.mhra.gov.uk>.

MHRA Yellow Card Scheme. Online. Available:<http://yellowcard.mhra.gov.uk>.

Pharmaceutical Services Negotiating Committee (PSNC) Online. Available:<www.psnc.org.uk>.

Randall, M., Neil, K.E.Disease management. London: Pharmaceutical Press, 2004.

Sexton, J., Nickless, G., Green, C.Pharmaceutical care made easy. London: Pharmaceutical Press, 2006.

World Health Organization. WHO regional monitoring center. Online. Available:<www.who-umc.org>.

Appendix 3: Latin terms and abbreviations

Carter, S.Dispensing for pharmaceutical students, 13th edn. London: Pitman Medical, 1975.

Wade E., ed. Pharmaceutical handbook, 19th edn. London: Pharmaceutical Press, 1980.